Integrated Advisors Network’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-2,281
| Closed | -$205K | – | 774 |
|
2024
Q4 | $205K | Sell |
2,281
-26
| -1% | -$2.34K | 0.01% | 662 |
|
2024
Q3 | $228K | Sell |
2,307
-82
| -3% | -$8.1K | 0.01% | 652 |
|
2024
Q2 | $221K | Sell |
2,389
-4,604
| -66% | -$427K | 0.01% | 633 |
|
2024
Q1 | $664K | Buy |
+6,993
| New | +$664K | 0.03% | 388 |
|
2023
Q1 | – | Sell |
-2,904
| Closed | -$241K | – | 701 |
|
2022
Q4 | $241K | Buy |
+2,904
| New | +$241K | 0.02% | 547 |
|
2022
Q3 | – | Sell |
-7,282
| Closed | -$541K | – | 697 |
|
2022
Q2 | $541K | Buy |
7,282
+4,746
| +187% | +$353K | 0.04% | 397 |
|
2022
Q1 | $228K | Buy |
+2,536
| New | +$228K | 0.01% | 608 |
|
2021
Q3 | – | Sell |
-1,544
| Closed | -$209K | – | 638 |
|
2021
Q2 | $209K | Hold |
1,544
| – | – | 0.02% | 551 |
|
2021
Q1 | $209K | Sell |
1,544
-117
| -7% | -$15.8K | 0.02% | 507 |
|
2020
Q4 | $234K | Buy |
+1,661
| New | +$234K | 0.03% | 446 |
|